HIV and AIDS Trial, Recruiting NCT04512456 Sponsor: Instituto Nacional de Cardiologia de Laranjeiras Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT04512456
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with HIV for at least 5 years
  • People who have been on combination HIV medication (multiple antiretroviral drugs together) for at least 3 years
  • People who have no HIV-related symptoms and no opportunistic infections (illnesses that take advantage of a weakened immune system) at the time of joining the trial

Who may not be able to join:

  • People who exercise regularly
  • People who are malnourished or have significant nutritional deficiencies
  • People who have been diagnosed with any of the following conditions: coronary artery disease, ischemic diseases, lung disease, diabetes, Chagas disease, tuberculosis, heart failure, or high blood pressure
  • People who use a pacemaker, or who take antidepressant, heart rhythm, or blood pressure medications — particularly beta-blockers

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Julana P Borges, Dr, Rio de Janeiro State University

Phone: +552123340775

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Instituto Nacional de Cardiologia de Laranjeiras
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change from Baseline Blood Pressure at 3 months; Change from Baseline Heart Rate Variability at 3 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov